Contact haptens in emollients marketed in two European countries (Poland and Spain)

Main Article Content

K. Kunkiel
M. Sojewska
W. Feleszko

Keywords

Abstract

Introduction and objectives: Atopic dermatitis (AD) is the most common skin disease among pediatric patients, which affects up to 20% of children worldwide. Characterized by pruritus and eczema, it is also associated with improper skin barrier function and allergen sensitization. Here, we aimed to assess the presence of haptens in emollients marketed in two European countries: in Poland and Spain, as, firstly, these products are considered to be AD’s basic therapy, and, secondly, frequent application of potent sensitizers on atopic skin may result in contact dermatitis.


Materials and methods: We systematically searched for moisturizers explicitly described as ‘‘Atopic skin care’’ products in the most frequently visited online pharmacies in Poland and Spain.


Subsequently, we created a database of all products and compared their composition with 139 contact haptens listed in the European Baseline Series (EBS), Fragrance and Cosmetic Series.


Results: As of December 2018, our list comprised 159 and 111 emollients available on the Polish and Spanish markets, respectively. There were no ingredients listed in 28 (17.5%) products in Poland and 24 (21.6%) in Spain. Only 23 (17.5%) and 13 (14.8%) products were hapten free. The pattern of most common haptens was similar in both countries, including phenoxyethanol, tocopherol and tocopheryl acetate, undefined parfum in Poland and tocopherol, Phenoxyethanol, tocopheryl acetate and undefined parfum in Spain.


Conclusions: This study shows that a vast majority of products taken into consideration contain at least one potential contact hapten. These findings indicate a need for patient education about potentially allergenic ingredients and stronger cooperation between academia and cosmetic manufacturers.

Abstract 117 | PDF Downloads 91

References

1. Halling-Overgaard AS, Kezic S, Jakasa I, Engebretsen KA, Maibach H, Thyssen JP. Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol. 2017;177: 84-106.

2. Lagrelius M, Wahlgren CF. Atopic dermatitis at preschool age and contact allergy in adolescence: a population-based cohort study. Br J Dermatol. 2019;180:782-9.

3. Simonsen AB, Johansen JD, Deleuran M, Mortz CG, Sommerlund M. Contact allergy in children with atopic dermatitis: a systematic review. Br J Dermatol. 2017;177:395-405.

4. Lubbes S, Rustemeyer T, Sillevis Smitt JH, Schuttelaar ML, Middelkamp-Hup MA. Contact sensitization in Dutch children and adolescents with and without atopic dermatitis- a retrospective analysis. Contact Dermatitis. 2017;76: 151-9.

5. Thyssen JP, Johansen JD, Linneberg A, Menne T, Engkilde K. The association between contact sensitization and atopic disease by linkage of a clinical database and a nationwide patient registry. Allergy. 2012;67:1157-64.

6. de Waard-van der Spek FB, Andersen KE, Darsow U, Mortz CG, Orton D, Worm M, et al. Allergic contact dermatitis in children: which factors are relevant? (review of the literature). Pediatr Allergy Immunol. 2013;24:321-9.

7. Mailhol C, Lauwers-Cances V, Rance F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64:801-6.

8. Herro EM, Matiz C, Sullivan K, Hamann C, Jacob SE. Frequency of contact allergens in pediatric patients with atopic dermatitis. J Clin Aesthetic Dermatol. 2011;4:39-41.

9. Adams AK, Connolly SM. Allergic contact dermatitis from vitamin E: the experience at Mayo Clinic Arizona, 1987 to 2007. Dermatitis. 2010;21:199-202.

10. Schnuch A, Mildau G, Kratz EM, Uter W. Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products. Contact Dermatitis. 2011;65:167-74.

11. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32: 657-82.

12. Kreft B, Geier J. Preservative allergy: an enduring issue. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete; 2019.

13. Nath NS, Liu B, Green C, Atwater AR. Contact allergy to hydroperoxides of linalool and d-limonene in a US population. Dermatitis. 2017;28:313-6.

14. Deza G, Garcia-Bravo B, Silvestre JF, Pastor-Nieto MA, Gonzalez-Perez R, Heras-Mendaza F, et al. Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study. Contact Dermatitis. 2017;76: 74-80.

15. Osinka K, Karczmarz A, Krauze A, Feleszko W. Contact allergens in cosmetics used in atopic dermatitis: analysis of product composition. Contact Dermatitis. 2016;75:241-3.

16. Dumycz K, Kunkiel K, Feleszko W. Cosmetics for neonates and infants: haptens in products’ composition. Clin Trans Allergy. 2019;9:15.

17. Hamann CR, Bernard S, Hamann D, Hansen R, Thyssen JP. Is there a risk using hypoallergenic cosmetic pediatric products in the United States? J Allergy Clin Immunol. 2015;135:1070-1.